Schedule 13G ownership disclosure
IONIS PHARMACEUTICALS INC
Common Stock · CUSIP: 462222100
Event date: 2024-12-31
- Filing-level shares
- 11,465,413.00
- Percent of class
- 7.3%
- Capital World Investors
Shares: 11,465,413.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422849-25-000016
- Form type
- SCHEDULE 13G
- Filer
- Capital World Investors
- CIK
- CIK 1422849
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership